Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
MDAI 
Spectral AI Inc. (MDAI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: MDAI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $5.09
1 Year Target Price $5.09
| 2 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -45.06% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 55.07M USD | Price to earnings Ratio - | 1Y Target Price 5.09 |
Price to earnings Ratio - | 1Y Target Price 5.09 | ||
Volume (30-day avg) 3 | Beta 0.88 | 52 Weeks Range 0.82 - 3.25 | Updated Date 09/17/2025 |
52 Weeks Range 0.82 - 3.25 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.7 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -51.97% | Operating Margin (TTM) -41.92% |
Management Effectiveness
Return on Assets (TTM) -20.97% | Return on Equity (TTM) -2308.32% |
Valuation
Trailing PE - | Forward PE 45.87 | Enterprise Value 54189835 | Price to Sales(TTM) 2 |
Enterprise Value 54189835 | Price to Sales(TTM) 2 | ||
Enterprise Value to Revenue 1.97 | Enterprise Value to EBITDA -3.41 | Shares Outstanding 26731000 | Shares Floating 18907630 |
Shares Outstanding 26731000 | Shares Floating 18907630 | ||
Percent Insiders 29.44 | Percent Institutions 14.3 |
Upturn AI SWOT
Spectral AI Inc.
Company Overview
History and Background
Spectral AI, Inc. was founded to develop and commercialize its DeepViewu00ae System for burn wound assessment. The company focuses on providing objective, data-driven insights to improve burn care decision-making.
Core Business Areas
- Burn Wound Assessment: The core business revolves around the DeepViewu00ae System, an AI-driven imaging tool for assessing burn wound severity and predicting healing outcomes.
Leadership and Structure
The leadership team comprises experienced professionals in medical devices, AI, and healthcare. The company operates with a structure focused on research and development, clinical validation, and commercialization of its DeepViewu00ae System.
Top Products and Market Share
Key Offerings
- DeepViewu00ae System: The DeepViewu00ae System is the flagship product. It is an AI-driven imaging system that assesses burn wound severity and predicts healing probability. Market share data is not publicly available. Revenue from this product is not publicly available. Competitors include traditional burn assessment methods (clinical judgment, biopsies) and potentially emerging technologies in wound care imaging. Indirect competitors are companies in wound healing such as Integra LifeSciences.
Market Dynamics
Industry Overview
The burn care market is driven by the need for improved wound assessment and treatment strategies to reduce complications and improve patient outcomes. There's a growing trend towards advanced technologies and AI-driven solutions in wound care.
Positioning
Spectral AI is positioned as a leader in AI-driven burn wound assessment, offering a more objective and data-driven approach compared to traditional methods. Its competitive advantage lies in its proprietary DeepViewu00ae technology and its ability to predict healing outcomes.
Total Addressable Market (TAM)
The TAM for burn care technologies is estimated to be in the billions of dollars. Spectral AI is positioned to capture a significant portion of this TAM with its DeepViewu00ae System, particularly as adoption of AI-driven solutions increases.
Upturn SWOT Analysis
Strengths
- Proprietary DeepViewu00ae technology
- AI-driven objective assessment
- Potential to improve burn care outcomes
- Strong intellectual property position
Weaknesses
- Limited commercialization experience
- Reliance on DeepViewu00ae System success
- High initial cost of DeepViewu00ae System
- Requirement for significant clinical validation
Opportunities
- Expansion into other wound care applications
- Partnerships with hospitals and burn centers
- Increased adoption of AI in healthcare
- Potential for reimbursement from insurance providers
Threats
- Competition from traditional burn assessment methods
- Emergence of alternative technologies
- Regulatory hurdles
- Resistance from healthcare providers to adopt new technologies
Competitors and Market Share
Key Competitors
- ISRG
- BSX
- ABT
Competitive Landscape
Spectral AI faces competition from established medical device companies and traditional burn assessment methods. Its advantage lies in its AI-driven approach, but it needs to overcome barriers to adoption and demonstrate clear clinical and economic benefits.
Growth Trajectory and Initiatives
Historical Growth: Limited historical growth data available as Spectral AI is in early stages of commercialization.
Future Projections: Future growth is projected to be driven by increased adoption of the DeepViewu00ae System and expansion into new markets.
Recent Initiatives: Recent initiatives include completing clinical trials, seeking regulatory approvals, and establishing partnerships with key opinion leaders in burn care.
Summary
Spectral AI is a novel AI-driven company in burn care wound analysis. It has the potential to revolutionize how burn wounds are assessed. The company needs to focus on commercializing DeepView, getting regulatory approvals, and securing partnerships. It is a risky investment that needs to be monitored for clinical benefits and adoption.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Press Releases
- Industry Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor. Market share data is based on estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Spectral AI Inc.
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 2021-04-06 | Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO Mr. Wensheng Fan | ||
Sector Healthcare | Industry Medical Devices | Full time employees 78 | Website https://www.spectral-ai.com |
Full time employees 78 | Website https://www.spectral-ai.com | ||
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.